Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 41Prostatic Neoplasms 32Ovarian Neoplasms 23Testicular Neoplasms 18Carcinoma, Transitional Cell 16Carcinoma, Renal Cell 16Carcinoma, Non-Small-Cell Lung 15Neoplasms 13Melanoma 13Testicular Germ Cell Tumor 12Colorectal Neoplasms 12Breast Neoplasms 12Neoplasm Metastasis 10Urethral Neoplasms 9Stomach Neoplasms 9Lung Neoplasms 9Endodermal Sinus Tumor 9Teratoma 8Pancreatic Neoplasms 8Central Nervous System Neoplasms 8Carcinoma, Embryonal 8Carcinoma, Ovarian Epithelial 7Triple Negative Breast Neoplasms 6Seminoma 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Esophageal Neoplasms 5Endometrial Neoplasms 5Penile Neoplasms 4

Interventions

Peripheral Blood Stem Cell Transplantation 3Filgrastim 3Cisplatin 3liposomal amphotericin B 2Therapeutics 2Radiotherapy 2Ifosfamide 2Etoposide 2Cyclophosphamide 2Bleomycin 2sargramostim 1aldesleukin 1Taxes 1Ribavirin 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Palivizumab 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Itraconazole 1Ipilimumab 1Interleukin-12 Subunit p35 1Interleukin-11 1Interferon-alpha 1In Situ Hybridization 1Immunologic Techniques 1Immunohistochemistry 1Gene Expression Profiling 1Fluorodeoxyglucose F18 1Fluconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Teratoma, Testicular × Paclitaxel × Genitourinary × Clear all
NCT00004077 2013-12-19

Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer

National Cancer Institute (NCI)

Phase 2 Completed
25 enrolled
Genitourinary

Teratoma, Testicular, Testicular Germ Cell Tumor, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡